Concepedia

Krishnansu S. Tewari

KS

130

Publications

11.4K

Citations

50

H-Index

1997

Active since

Affiliations

University of California, Irvine Medical Center(Current)

University of California, Irvine

Roswell Park Comprehensive Cancer Center

Creighton University

University of Arizona

Krishnansu S. Tewari is an author at University of California, Irvine Medical Center specializing in medicine, oncology, and obstetrics.

ORCID

Top concepts

Publications per year

1997–2025

130

Publications

130

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari, Michael W. Sill, Harry J. Long et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Nicoletta Colombo, Coraline Dubot, Domenica Lorusso et al. · New England Journal of Medicine · 2021 · 923 citations · Full text

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al. · The Lancet · 2017 · 656 citations · Full text

, , +11

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Robert L. Coleman, Mark F. Brady, Thomas J. Herzog et al. · The Lancet Oncology · 2017 · 585 citations · Full text

, , +9

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 461 citations · Full text

Rows per page

1–5 of 130